Browsing by Author ALLEN B.j.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2006JRC35134Control of Prostate Cancer Spheroid Growth Using (213)Bi-labeled Multiple Targeted Alpha RadioimmunoconjugatesWANG J.; RIZVI S.m.a.; MADIGAN C.; COZZI P.j.; POWER C.a.; QU C.f.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; RUSSEL P.j.; ALLEN B.j., et alArticles in periodicals and books
2004JRC29295MUC1 Expression in Primary and Metastatic Pancreatic Cancer Cells for in vitro Treatment by 213Bi-C595 RadioimmunoconjugateQU Chang f.; LI Yong; SONG Yang j.; RIZVI S.m.a.; RAJA Chand; ZHANG D.; SAMRA J.; SMITH R.; PERKINS A.c.; APOSTOLIDIS Christos, et alArticles in periodicals and books
2012JRC70139Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.Articles in periodicals and books
2006JRC35141Preclinical Studies of Bismuth-213 Labeled Plasminogen Activator Inhibitor Type 2 (PAI2) in a Prostate Cancer Nude Mouse Xenograft ModelRIZVI S.m.a.; LI Y.; SONG E.; QU C.f.; RAJA C.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B.j.Articles in periodicals and books
2005JRC28667Targeted Alpha Therapy with 213 Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer.QU Chang f.; SONG Yang j.; LI Yong; RIZVI S.m.a.; RAJA Chand; SMITH R.; MORGENSTERN A.; APOSTOLIDIS Christos; ALLEN B.j.Articles in periodicals and books